Cara Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
39.29 M |
Public Float |
27.93 M |
Cara Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.11 |
Market Cap |
$866.99 M |
Shares Outstanding |
39.75 M |
Public Float |
34.8 M |
Address |
4 Stamford Plaza Stamford Connecticut 06902 United States |
Employees | - |
Website | http://www.caratherapeutics.com |
Updated | 07/08/2019 |
CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. |